[1]
|
Siehler, J., Blöchinger, A.K., Meier, M. and Lickert, H. (2021) Engineering Islets from Stem Cells for Advanced Therapies of Diabetes. Nature Reviews Drug Discovery, 20, 920-940. https://doi.org/10.1038/s41573-021-00262-w
|
[2]
|
Dial, A.G., Monaco, C.M.F., Grafham, G.K., Romanova, N., Simpson, J.A., Tarnopolsky, M.A., Perry, C.G.R., Kalaitzoglou, E. and Hawke, T.J. (2020) Muscle and Serum Myostatin Expression in Type 1 Diabetes. Physiological Reports, 8, e14500. https://doi.org/10.14814/phy2.14500
|
[3]
|
Lee, E.J., Ahmad, S.S., Lim, J.H., Ahmad, K., Shaikh, S., Lee, Y.S., Park, S.J., Jin, J.O., Lee, Y.H. and Choi, I. (2021) Interaction of Fibromodulin and Myostatin to Regulate Skeletal Muscle Aging: An Opposite Regulation in Muscle Aging, Diabetes, and Intracellular Lipid Accumulation. Cells, 10, Article No. 2083. https://doi.org/10.3390/cells10082083
|
[4]
|
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K.B., Ostolaza, H. and Martín, C. (2020) Pathophysiology of Type 2 Diabetes Mellitus. International Journal of Molecular Sciences, 21, Article No. 6275. https://doi.org/10.3390/ijms21176275
|
[5]
|
Rizzo, M.R., Di Meo, I., Polito, R., Auriemma, M.C., Gambardella, A., di Mauro, G., Capuano, A. and Paolisso, G. (2022) Cognitive Impairment and Type 2 Diabetes Mellitus: Focus of SGLT2 Inhibitors Treatment. Pharmacological Research, 176, Article ID: 106062. https://doi.org/10.1016/j.phrs.2022.106062
|
[6]
|
Daradics, Z., Crecan, C.M., Rus, M.A., Morar, I.A., Mircean, M.V., Cătoi, A.F., Cecan, A.D. and Cătoi, C. (2021) Obesity-Related Metabolic Dysfunction in Dairy Cows and Horses: Comparison to Human Metabolic Syndrome. Life (Basel), 11, Article No. 1406. https://doi.org/10.3390/life11121406
|
[7]
|
Barbalho, S.M., Prado Neto, E.V., De Alvares Goulart, R., Bechara, M.D., Baisi Chagas, E.F., Audi, M., Guissoni Campos, L.M., Landgraf Guiger, E., Buchaim, R.L., Buchaim, D.V. and Cressoni Araujo, A. (2020) Myokines: A Descriptive Review. The Journal of Sports Medicine and Physical Fitness, 60, 1583-1590. https://doi.org/10.23736/S0022-4707.20.10884-3
|
[8]
|
Liu, C., Feng, X., Li, Q., Wang, Y., Li, Q. and Hua, M. (2016) Adiponectin, TNF-α and Inflammatory Cytokines and Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis. Cytokine, 86, 100-109. https://doi.org/10.1016/j.cyto.2016.06.028
|
[9]
|
Whitham, M. and Febbraio, M.A. (2016) The Ever-Expanding Myokinome: Discovery Challenges and Therapeutic Implications. Nature Reviews Drug Discovery, 15, 719-729. https://doi.org/10.1038/nrd.2016.153
|
[10]
|
Febbraio, M.A. and Pedersen, B.K. (2020) Who Would Have Thought-Myokines Two Decades on. Nature Reviews Endocrinology, 16, 619-620. https://doi.org/10.1038/s41574-020-00408-7
|
[11]
|
Lehrskov, L.L. and Christensen, R.H. (2019) The Role of Interleukin-6 in Glucose Homeostasis and Lipid Metabolism. Seminars in Immunopathology, 41, 491-499. https://doi.org/10.1007/s00281-019-00747-2
|
[12]
|
Fève, B. and Bastard, J.P. (2009) The Role of Interleukins in Insulin Resistance and Type 2 Diabetes Mellitus. Nature Reviews Endocrinology, 5, 305-311. https://doi.org/10.1038/nrendo.2009.62
|
[13]
|
Kurauti, M.A., Costa-Júnior, J.M., Ferreira, S.M., Santos, G.J., Sponton, C.H.G., Carneiro, E.M., Telles, G.D., Chacon-Mikahil, M.P.T., Cavaglieri, C.R., Rezende, L.F. and Boschero, A.C. (2017) Interleukin-6 Increases the Expression and Activity of Insulin-Degrading Enzyme. Scientific Reports, 7, Article No. 46750. https://doi.org/10.1038/srep46750
|
[14]
|
Akbari, M. and Hassan-Zadeh, V. (2018) IL-6 Signalling Pathways and the Development of Type 2 Diabetes. Inflammopharmacology, 26, 685-698. https://doi.org/10.1007/s10787-018-0458-0
|
[15]
|
Ghanem, S.E., Abdel-Samiee, M., Torky, M.H., Gaafar, A., Mohamed, S.M., Salah Eldin, G.M.M., Awad, S.M., Diab, K.A., DM, E.L., Yehia, S.A., Abdelaziz Elbasyouni, H.A. and Elshormilisy, A.A. (2020) Role of Resistin, IL-6 and NH2-Terminal Portion proBNP in the Pathogenesis of Cardiac Disease in Type 2 Diabetes Mellitus. BMJ Open Diabetes Research & Care, 8, e001206. https://doi.org/10.1136/bmjdrc-2020-001206
|
[16]
|
Adela, R., Reddy, P.N.C., Ghosh, T.S., Aggarwal, S., Yadav, A.K., Das, B. and Banerjee, S.K. (2019) Serum Protein Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus. Journal of Translational Medicine, 17, Article No. 17. https://doi.org/10.1186/s12967-018-1755-5
|
[17]
|
Moshapa, F.T., Riches-Suman, K. and Palmer, T.M. (2019) Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus. Cardiology Research and Practice, 2019, Article ID: 9846312. https://doi.org/10.1155/2019/9846312
|
[18]
|
Hong, E.G., Ko, H.J., Cho, Y.R., Kim, H.J., Ma, Z., Yu, T.Y., Friedline, R.H., Kurt-Jones, E., Finberg, R., Fischer, M.A., Granger, E.L., Norbury, C.C., Hauschka, S.D., Philbrick, W.M., Lee, C.G., Elias, J.A. and Kim, J.K. (2009) Interleukin-10 Prevents Diet-Induced Insulin Resistance by Attenuating Macrophage and Cytokine Response in Skeletal Muscle. Diabetes, 58, 2525-2535. https://doi.org/10.2337/db08-1261
|
[19]
|
Straczkowski, M., Kowalska, I., Nikolajuk, A., Krukowska, A. and Gorska, M. (2005) Plasma Interleukin-10 Concentration Is Positively Related to Insulin Sensitivity in Young Healthy Individuals. Diabetes Care, 28, 2036-2037. https://doi.org/10.2337/diacare.28.8.2036
|
[20]
|
van Exel, E., J. Gussekloo, A.J. de Craen, M. Frölich, A. Bootsma-Van Der Wiel, and R.G. Westendorp, (2002) Low Production Capacity of Interleukin-10 Associates with the Metabolic Syndrome and Type 2 Diabetes: The Leiden 85-plus Study. Diabetes, 51, 1088-1092. https://doi.org/10.2337/diabetes.51.4.1088
|
[21]
|
Yssel, H., De Waal Malefyt, R., Roncarolo, M.G., Abrams, J.S., Lahesmaa, R., Spits, H. and de Vries, J.E. (1992) IL-10 Is Produced by Subsets of Human CD4+ T Cell Clones and Peripheral Blood T Cells. The Journal of Immunology, 149, 2378-2384.
|
[22]
|
Moore, K.W., de Waal Malefyt, R., Coffman, R.L. and O’Garra, A. (2001) Interleukin-10 and the Interleukin-10 Receptor. Annual Review of Immunology, 19, 683-765. https://doi.org/10.1146/annurev.immunol.19.1.683
|
[23]
|
Yin, Y.W., Hu, A.M., Sun, Q.Q., Zhang, B.B., Liu, H.L., Wang, Q., Zeng, Y.H., Xu, R.J., Zhang, S.J. and Shi, L.B. (2013) Association between Interleukin 10 Gene-1082 A/G Polymorphism and the Risk of Type 2 Diabetes Mellitus: A Meta-Analysis of 4250 Subjects. Cytokine, 62, 226-231. https://doi.org/10.1016/j.cyto.2013.02.025
|
[24]
|
Forte, G.I., Pilato, G., Vaccarino, L., Sanacore, M., Candore, G., Romano, G.C., Testa, R., Franceschi, C., Capri, M., Marra, M., Bonfigli, A.R., Caruso, C., Scola, L. and Lio, D. (2010) Risk Profiles in Type 2 Diabetes (Metabolic Syndrome): Integration of IL-10 Polymorphisms and Laboratory Parameters to Identify Vascular Damages Related Complications. Current Pharmaceutical Design, 16, 898-903. https://doi.org/10.2174/138161210790883642
|
[25]
|
Chang, J.S., Chang, C.C., Chien, E., Lin, S.S., Cheng-Shiuan, T., Bai, C.H. and Chao, K.C. (2013) Association between Interleukin 1β and Interleukin 10 Concentrations: A Cross-Sectional Study in Young Adolescents in Taiwan. BMC Pediatrics, 13, Article No. 123. https://doi.org/10.1186/1471-2431-13-123
|
[26]
|
Zeng, J., Xu, Y., Shi, Y. and Jiang, C. (2018) Inflammation Role in Sensory Neuropathy in Chinese Patients with Diabetes/Prediabetes. Clinical Neurology and Neurosurgery, 166, 136-140. https://doi.org/10.1016/j.clineuro.2018.01.031
|
[27]
|
Pedersen, B.K., Akerström, T.C., Nielsen, A.R. and Fischer, C.P. (2007) Role of Myokines in Exercise and Metabolism. Journal of Applied Physiology (1985), 103, 1093-1098. https://doi.org/10.1152/japplphysiol.00080.2007
|
[28]
|
Jabri, B. and Abadie, V. (2015) IL-15 Functions as a Danger Signal to Regulate Tissue-Resident T Cells and Tissue Destruction. Nature Reviews Immunology, 15, 771-783. https://doi.org/10.1038/nri3919
|
[29]
|
Pérez-López, A., Martin-Rincon, M., Santana, A., Perez-Suarez, I., Dorado, C., Calbet, J.A.L. and Morales-Alamo, D. (2019) Antioxidants Facilitate High-Intensity Exercise IL-15 Expression in Skeletal Muscle. International Journal of Sports Medicine, 40, 16-22. https://doi.org/10.1055/a-0781-2527
|
[30]
|
Christiansen, T., Bruun, J.M., Paulsen, S.K., Olholm, J., Overgaard, K., Pedersen, S.B. and Richelsen, B. (2013) Acute Exercise Increases Circulating Inflammatory Markers in Overweight and Obese Compared with Lean Subjects. European Journal of Applied Physiology, 113, 1635-1642. https://doi.org/10.1007/s00421-013-2592-0
|
[31]
|
Wadenpohl, J., Seyfarth, J., Hehenkamp, P., Hoffmann, M., Kummer, S., Reinauer, C., Döing, C., Förtsch, K., Mayatepek, E., Meissner, T. and Jacobsen, M. (2021) CD5-Expressing CD8(+) T-Cell Subsets Differ between Children with Type 1 Diabetes and Controls. Immunology & Cell Biology, 99, 1077-1084. https://doi.org/10.1111/imcb.12488
|
[32]
|
Stocks, B.T., Wilson, C.S., Marshall, A.F., Hoopes, E.M. and Moore, D.J. (2019) Regulation of Diabetogenic Immunity by IL-15-Activated Regulatory CD8 T Cells in Type 1 Diabetes. The Journal of Immunology, 203, 158-166. https://doi.org/10.4049/jimmunol.1800976
|
[33]
|
Ge, T., Jhala, G., Fynch, S., Akazawa, S., Litwak, S., Pappas, E.G., Catterall, T., Vakil, I., Long, A.J., Olson, L.M., Krishnamurthy, B., Kay, T.W. and Thomas, H.E. (2020) The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice. Frontiers in Immunology, 11, Article ID: 588543. https://doi.org/10.3389/fimmu.2020.588543
|
[34]
|
Nadeau, L. and Aguer, C. (2019) Interleukin-15 as a Myokine: Mechanistic Insight into Its Effect on Skeletal Muscle Metabolism. Applied Physiology, Nutrition, and Metabolism, 44, 229-238. https://doi.org/10.1139/apnm-2018-0022
|
[35]
|
Nagrani, R., Foraita, R., Wolters, M., De Henauw, S., Marild, S., Molnár, D., Moreno, L.A., Russo, P., Tornaritis, M., Veidebaum, T., Ahrens, W. and Marron, M. (2021) Longitudinal Association of Inflammatory Markers with Markers of Glycaemia and Insulin Resistance in European Children. Diabetes/Metabolism Research and Reviews, 38, e3511. https://doi.org/10.1002/dmrr.3511
|
[36]
|
McPherron, A.C., Lawler, A.M. and Lee, S.J. (1997) Regulation of Skeletal Muscle Mass in Mice by a New TGF-beta Superfamily Member. Nature, 387, 83-90. https://doi.org/10.1038/387083a0
|
[37]
|
Amor, M., Itariu, B.K., Moreno-Viedma, V., Keindl, M., Jürets, A., Prager, G., Langer, F., Grablowitz, V., Zeyda, M. and Stulnig, T.M. (2019) Serum Myostatin Is Upregulated in Obesity and Correlates with Insulin Resistance in Humans. Experimental and Clinical Endocrinology & Diabetes, 127, 550-556. https://doi.org/10.1055/a-0641-5546
|
[38]
|
Eilers, W., Cleasby, M. and Foster, K. (2021) Development of Antisense-Mediated Myostatin Knockdown for the Treatment of Insulin Resistance. Scientific Reports, 11, Article No. 1604. https://doi.org/10.1038/s41598-021-81222-7
|
[39]
|
Chung, J.O., Park, S.Y., Chung, D.J. and Chung, M.Y. (2020) Serum Myostatin Levels Are Positively Associated with Diabetic Retinopathy in Individuals with Type 2 Diabetes Mellitus. Journal of Diabetes and Its Complications, 34, Article ID: 107592. https://doi.org/10.1016/j.jdiacomp.2020.107592
|
[40]
|
Efthymiadou, A., Vasilakis, I.A., Giannakopoulos, A. and Chrysis, D. (2021) Myostatin Serum Levels in Children with Type 1 Diabetes Mellitus. Hormones (Athens), 20, 777-782. https://doi.org/10.1007/s42000-021-00317-y
|
[41]
|
Kang, M.J., Moon, J.W., Lee, J.O., Kim, J.H., Jung, E.J., Kim, S.J., Oh, J.Y., Wu, S.W., Lee, P.R., Park, S.H. and Kim, H.S. (2022) Metformin Induces Muscle Atrophy by Transcriptional Regulation of Myostatin via HDAC6 and FoxO3a. Journal of Cachexia, Sarcopenia and Muscle, 13, 605-620. https://doi.org/10.1002/jcsm.12833
|
[42]
|
Yamakage, H., Tanaka, M., Inoue, T., Odori, S., Kusakabe, T. and Satoh-Asahara, N. (2020) Effects of Dapagliflozin on the Serum Levels of Fibroblast Growth Factor 21 and Myokines and Muscle Mass in Japanese Patients with Type 2 Diabetes: A Randomized, Controlled Trial. Journal of Diabetes Investigation, 11, 653-661. https://doi.org/10.1111/jdi.13179
|
[43]
|
Kazemi, F. (2019) Myostatin Alters with Exercise Training in Diabetic Rats; Possible Interaction with Glycosylated Hemoglobin and Inflammatory Cytokines. Cytokine, 120, 99-106. https://doi.org/10.1016/j.cyto.2019.04.012
|
[44]
|
Motahari Rad, M., Bijeh, N., Attarzadeh Hosseini, S.R. and Raouf Saeb, A. (2020) The Effect of Two Concurrent Exercise Modalities on Serum Concentrations of FGF21, Irisin, Follistatin, and Myostatin in Men with Type 2 Diabetes Mellitus. Archives of Physiology and Biochemistry, 12, 1-10. https://doi.org/10.1080/13813455.2020.1829649
|
[45]
|
Zhang, A., Li, M., Wang, B., Klein, J.D., Price, S.R. and Wang, X.H. (2018) miRNA-23a/27a Attenuates Muscle Atrophy and Renal Fibrosis through Muscle-Kidney Crosstalk. Journal of Cachexia, Sarcopenia and Muscle, 9, 755-770. https://doi.org/10.1002/jcsm.12296
|
[46]
|
Zhao, B., Han, X., Meng, Q. and Luo, Q. (2018) Early Second Trimester Maternal Serum Markers in the Prediction of Gestational Diabetes Mellitus. Journal of Diabetes Investigation, 9, 967-974. https://doi.org/10.1111/jdi.12798
|
[47]
|
Li, B., Cui, W. and Yang, J. (2020) Enhanced Skeletal Muscle Growth in Myostatin-Deficient Transgenic Pigs Had Improved Glucose Uptake in Stretozotocin-Induced Diabetes. Transgenic Research, 29, 253-261. https://doi.org/10.1007/s11248-020-00194-y
|
[48]
|
Zubair, M. and Ahmad, J. (2019) Role of Growth Factors and Cytokines in Diabetic Foot Ulcer Healing: A Detailed Review. Reviews in Endocrine and Metabolic Disorders, 20, 207-217. https://doi.org/10.1007/s11154-019-09492-1
|
[49]
|
Suh, J.M., Jonker, J.W., Ahmadian, M., Goetz, R., Lackey, D., Osborn, O., Huang, Z., Liu, W., Yoshihara, E., van Dijk, T.H., Havinga, R., Fan, W., Yin, Y.Q., Yu, R.T., Liddle, C., Atkins, A.R., Olefsky, J.M., Mohammadi, M., Downes, M. and Evans, R.M. (2014) Endocrinization of FGF1 Produces a Neomorphic and Potent Insulin Sensitizer. Nature, 513, 436-439. https://doi.org/10.1038/nature13540
|
[50]
|
Kolodziejski, P.A., Sassek. M., Bien. J., Leciejewska. N., Szczepankiewicz. D., Szczepaniak, B., Wojciechowska. M., Nogowski. L., Nowak. K.W., Strowski, M.Z. and Pruszynska-Oszmalek, E. (2020) FGF-1 Modulates Pancreatic β-Cell Functions/Metabolism: An in Vitro Study. General and Comparative Endocrinology, 294, Article ID: 113498. https://doi.org/10.1016/j.ygcen.2020.113498
|
[51]
|
Liang, G., Song, L., Chen, Z., Qian, Y., Xie, J., Zhao, L., Lin, Q., Zhu, G., Tan, Y., Li, X., Mohammadi, M. and Huang, Z. (2018) Fibroblast Growth Factor 1 Ameliorates Diabetic Nephropathy by an Anti-Inflammatory Mechanism. Kidney International, 93, 95-109. https://doi.org/10.1016/j.kint.2017.05.013
|
[52]
|
Ying, L., Wang, L., Guo, K., Hou, Y., Li, N., Wang, S., Liu, X., Zhao, Q., Zhou, J., Zhao, L., Niu, J., Chen, C., Song, L., Hou, S., Kong, L., Li, X., Ren, J., Li, P., Mohammadi, M. and Huang, Z. (2021) Paracrine FGFs Target Skeletal Muscle to Exert Potent Anti-Hyperglycemic Effects. Nature Communications, 12, Article No. 7256. https://doi.org/10.1038/s41467-021-27584-y
|
[53]
|
Morton, G.J., Matsen, M.E., Bracy, D.P., Meek, T.H., Nguyen, H.T., Stefanovski, D., Bergman, R.N., Wasserman, D.H. and Schwartz, M.W. (2013) FGF19 Action in the Brain Induces Insulin-Independent Glucose Lowering. Journal of Clinical Investigation, 123, 4799-4808. https://doi.org/10.1172/JCI70710
|
[54]
|
Dolegowska, K., Marchelek-Mysliwiec, M., Nowosiad-Magda, M., Slawinski, M. and Dolegowska, B. (2019) FGF19 Subfamily Members: FGF19 and FGF21. Journal of Physiology and Biochemistry, 75, 229-240. https://doi.org/10.1007/s13105-019-00675-7
|
[55]
|
Taniguchi, H., Akiyama, N. and Ishihara, K. (2019) Hepatic Fat Content Is Associated with Fasting-Induced Fibroblast Growth Factor 21 Secretion in Mice Fed Soy Proteins. Journal of Nutritional Science and Vitaminology (Tokyo), 65, 515-525. https://doi.org/10.3177/jnsv.65.515
|
[56]
|
Li, J., Xu, C., Liu, Y., Li, Y., S. Du, Zhang, R., Sun, Y., Zhang, R., Wang, Y., Xue, H., Ni, S., Asiya, M., Xue, G., Li, Y., Shi, L., Li, D., Pan, Z., Zhang, Y., Wang, Z., Cai, B., Wang, N. and Yang, B. (2020) Fibroblast Growth Factor 21 Inhibited Ischemic Arrhythmias via Targeting miR-143/EGR1 Axis. Basic Research in Cardiology, 115, 9. https://doi.org/10.1007/s00395-019-0768-4
|
[57]
|
Yao, Z., Lin, P., Wang, C., Wang, K. and Sun, Y. (2021) Administration of Metrnl Delays the Onset of Diabetes in Non-Obese Diabetic Mice. Endocrine Journal, 68, 179-188. https://doi.org/10.1507/endocrj.EJ20-0351
|
[58]
|
Hu, W., Wang, R. and Sun, B. (2021) Meteorin-Like Ameliorates β Cell Function by Inhibiting β Cell Apoptosis of and Promoting β Cell Proliferation via Activating the WNT/β-Catenin Pathway. Frontiers in Pharmacology, 12, Article ID: 627147. https://doi.org/10.3389/fphar.2021.627147
|
[59]
|
Dadmanesh, M., Aghajani, H., Fadaei, R. and Ghorban, K. (2018) Lower Serum Levels of Meteorin-Like/Subfatin in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Are Negatively Associated with Insulin Resistance and Inflammatory Cytokines. PLOS ONE, 13, e0204180. https://doi.org/10.1371/journal.pone.0204180
|
[60]
|
El-Ashmawy, H.M., Selim, F.O., Hosny, T.A.M. and Almassry, H.N. (2019) Association of Low Serum Meteorin Like (Metrnl) Concentrations with Worsening of Glucose Tolerance, Impaired Endothelial Function and Atherosclerosis. Diabetes Research and Clinical Practice, 150, 57-63. https://doi.org/10.1016/j.diabres.2019.02.026
|
[61]
|
Fadaei, R., Dadmanesh, M., Moradi, N., Ahmadi, R., Shokoohi Nahrkhalaji, A., Aghajani, H. and Ghorban, K. (2020) Serum Levels of Subfatin in Patients with Type 2 Diabetes Mellitus and Its Association with Vascular Adhesion Molecules. Archives of Physiology and Biochemistry, 126, 335-340. https://doi.org/10.1080/13813455.2018.1538248
|
[62]
|
Chung, H.S., Hwang, S.Y., Choi, J.H., Lee, H.J., Kim, N.H., Yoo, H.J., Seo, J.A., Kim, S.G., Kim, N.H., Baik, S.H. and Choi, K.M. (2018) Implications of Circulating Meteorin-Like (Metrnl) Level in Human Subjects with Type 2 Diabetes. Diabetes Research and Clinical Practice, 136, 100-107. https://doi.org/10.1016/j.diabres.2017.11.031
|
[63]
|
Wu, Q., Dan, Y.L., He, Y.S., Xiang, K., Hu, Y.Q., Zhao, C.N., Zhong, X., Wang, D.G. and Pan, H.F. (2020) Circulating Meteorin-Like Levels in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis. Current Pharmaceutical Design, 26, 5732-5738. https://doi.org/10.2174/1381612826666201007163930
|
[64]
|
Ali, E.Y., Hegazy, G.A. and Hashem, E.M. (2020) Evaluation of Irisin, Retinol-Binding Protein 4, and Leptin Serum Levels as Biomarkers of Macrovascular Complications Involvement in Saudi Type 2 Diabetes Mellitus. A Case-Control Study. Saudi Medical Journal, 41, 1369-1374. https://doi.org/10.15537/smj.2020.12.25461
|
[65]
|
Tarboush, N.A., Abu-Yaghi, N.E., Al Ejeilat, L.H., Wahed, R.K.A. and Jeris, I.N. (2021) Association of Irisin Circulating Level with Diabetic Retinopathy: A Case-Control Study. Experimental and Clinical Endocrinology & Diabetes, 129, 36-42. https://doi.org/10.1055/a-0723-3749
|
[66]
|
Zhu, D., Zhang, X., Wang, F., Ye, Q., Yang, C. and Liu, D. (2022) Irisin Rescues Diabetic Cardiac Microvascular Injury via ERK1/2/Nrf2/HO-1 Mediated Inhibition of Oxidative Stress. Diabetes Research and Clinical Practice, 183, Article ID: 109170. https://doi.org/10.1016/j.diabres.2021.109170
|
[67]
|
Song, R., Zhao, X., Cao, R., Liang, Y., Zhang, D.Q. and Wang, R. (2021) Irisin Improves Insulin Resistance by Inhibiting Autophagy through the PI3K/Akt Pathway in H9c2 Cells. Gene, 769, Article ID: 145209. https://doi.org/10.1016/j.gene.2020.145209
|
[68]
|
Duan, H., Ma, B., Ma, X., Wang, H., Ni, Z., Wang, B., Li, X., Jiang, P., Umar, M. and Li, M. (2016) Anti-Diabetic Activity of Recombinant Irisin in STZ-Induced Insulin-Deficient Diabetic Mice. International Journal of Biological Macromolecules, 84, 457-463. https://doi.org/10.1016/j.ijbiomac.2015.12.049
|
[69]
|
Yang, M., Chen, P., Jin, H., Xie, X., Gao, T., Yang, L. and Yu, X. (2014) Circulating Levels of Irisin in Middle-Aged First-Degree Relatives of Type 2 Diabetes Mellitus—Correlation with Pancreatic β-Cell Function. Diabetology & Metabolic Syndrome, 6, Article No. 133. https://doi.org/10.1186/1758-5996-6-133
|